EUROAPI aims to be the leading player in active pharmaceutical ingredient (API) manufacturing in Europe, delivering products and services that meet customer needs and contribute to better health outcomes and improved quality of life for patients around the world.
We offer innovative and inherently sustainable processes and services. Our commitment includes safe products, a flexible and responsible supply chain, and outstanding product quality — making us a reliable partner in the pharmaceutical supply chain.
We are currently a global leader in the production of small molecule APIs and the world’s leading developer and manufacturer of prostaglandins.
Our strong innovation and R&D capabilities enable us to support our partners’ success through our CDMO (Contract Development and Manufacturing Organization) services.
Hungary has a long-standing tradition in pharmaceutical manufacturing. After several corporate transformations, EUROAPI has become one of the largest API producers in the country. As of 2024, our Hungarian site employs more than 950 people across production, research & development, and internal IT services.